HCA Healthcare, Inc. $HCA Shares Sold by Mitsubishi UFJ Trust & Banking Corp

Mitsubishi UFJ Trust & Banking Corp lessened its stake in HCA Healthcare, Inc. (NYSE:HCA) by 2.7% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 190,092 shares of the company’s stock after selling 5,313 shares during the period. Mitsubishi UFJ Trust & Banking Corp’s holdings in HCA Healthcare were worth $81,017,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Brighton Jones LLC acquired a new position in HCA Healthcare in the 4th quarter valued at about $1,021,000. NewEdge Advisors LLC grew its holdings in shares of HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after purchasing an additional 409 shares in the last quarter. Sivia Capital Partners LLC lifted its holdings in HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after buying an additional 33 shares in the last quarter. Farther Finance Advisors LLC increased its position in shares of HCA Healthcare by 22.6% during the second quarter. Farther Finance Advisors LLC now owns 1,399 shares of the company’s stock worth $536,000 after acquiring an additional 258 shares during the period. Finally, Fifth Third Bancorp boosted its holdings in HCA Healthcare by 2.0% in the second quarter. Fifth Third Bancorp now owns 9,350 shares of the company’s stock valued at $3,582,000 after purchasing an additional 186 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on HCA shares. Zacks Research cut HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 27th. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a report on Monday, December 29th. Stephens lifted their price objective on shares of HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. Robert W. Baird raised their price target on HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Finally, Royal Bank Of Canada increased their price objective on HCA Healthcare from $482.00 to $525.00 and gave the company an “outperform” rating in a report on Friday, December 19th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $488.75.

Insider Buying and Selling

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $470.52 on Friday. HCA Healthcare, Inc. has a 1 year low of $295.00 and a 1 year high of $520.00. The firm has a market cap of $107.37 billion, a price-to-earnings ratio of 18.19, a PEG ratio of 1.28 and a beta of 1.36. The stock’s 50-day moving average is $480.37 and its two-hundred day moving average is $433.53.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. During the same period in the prior year, the firm earned $4.90 EPS. The business’s revenue was up 9.6% on a year-over-year basis. As a group, research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.